News Focus
News Focus
icon url

DewDiligence

08/30/17 10:15 AM

#213346 RE: DewDiligence #213326

ADXS-NEO addendum: I’m surprised that melanoma—one of the most immunogenic cancers—is not one of the indications being tested in the phase-1 trial.